Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK)
Yang Lu, Haiying Sun
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 23, pp. 14382-14403
Closed Access | Times Cited: 71

Showing 26-50 of 71 citing articles:

The dual FAK-HDAC inhibitor MY-1259 displays potent activities in gastric cancers in vitro and in vivo
Jian Song, Xu Liu, Yifan Zhang, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106328-106328
Closed Access | Times Cited: 17
Integrin α3/α6 and αV are implicated in ADAM15-activated FAK and EGFR signalling pathway individually and promote non-small-cell lung cancer progression
Jieqi Zhou, Anqi Wang, Tingting Cai, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 15
Design, Synthesis and Antitumor Activity of FAK/PLK1 Dual Inhibitors with Quinazolinone as the Skeleton
Juan Sun, Ze‐Yu Fang, Yi‐Nuo Tao, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 4
Closed Access | Times Cited: 9
Design, synthesis and biological evaluation of 4-arylamino-pyrimidine derivatives as focal adhesion kinase inhibitors
Zhiwu Long, Yaqing Zuo, Rongrong Li, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106792-106792
Closed Access | Times Cited: 8
Design, synthesis and biological evaluation of novel 2,4-diaminopyrimidine cinnamyl derivatives as inhibitors of FAK with potent anti-gastric cancer activities
Yang Liu, Lijun Kong, Na Li, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106895-106895
Closed Access | Times Cited: 8
Synthesis of 1,3,4-Thiadiazole Derivatives and Their Anticancer Evaluation
Camelia Elena Stecoza, George Mihai Niţulescu, Constantin Drǎghici, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17476-17476
Open Access | Times Cited: 8
Techniques and Strategies in Drug Design and Discovery
George Mihai Niţulescu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1364-1364
Open Access | Times Cited: 2
Recently reported cell migration inhibitors: Opportunities and challenges for antimetastatic agents
Samuel K. Akompong, Yang Li, Wenxue Gong, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 3, pp. 103906-103906
Closed Access | Times Cited: 2
Chemical Probes for Understudied Kinases: Challenges and Opportunities
Ricardo Augusto Massarico Serafim, Jonathan M. Elkins, William J. Zuercher, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 2, pp. 1132-1170
Open Access | Times Cited: 20
Molecular Docking, Molecular Dynamics Simulations, and Free Energy Calculation Insights into the Binding Mechanism between VS-4718 and Focal Adhesion Kinase
Mingsong Shi, Tao Chen, Siping Wei, et al.
ACS Omega (2022) Vol. 7, Iss. 36, pp. 32442-32456
Open Access | Times Cited: 14
FAK-targeting PROTAC demonstrates enhanced antitumor activity against KRAS mutant non-small cell lung cancer
Jinyuan Liu, Lei Xue, Xiang Xu, et al.
Experimental Cell Research (2021) Vol. 408, Iss. 2, pp. 112868-112868
Closed Access | Times Cited: 18
Synthesis and evaluation of FAK inhibitors with a 5-fluoro-7H-pyrrolo[2,3-d]pyrimidine scaffold as anti-hepatocellular carcinoma agents
Hanyi Tan, Yue Liu, Chaochao Gong, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113670-113670
Closed Access | Times Cited: 17
Design, synthesis and biological evaluation of 7-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)-2,3-dihydro-1H-inden-1-one derivatives as potent FAK inhibitors for the treatment of ovarian cancer
Wei Wei, Zhanzhan Feng, Zhihao Liu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 228, pp. 113978-113978
Closed Access | Times Cited: 17
PLEKHH2 binds β-arrestin1 through its FERM domain, activates FAK/PI3K/AKT phosphorylation, and promotes the malignant phenotype of non-small cell lung cancer
Rui Wang, Si Wang, Zhen Li, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 11
Design, synthesis and biological evaluation of novel FAK inhibitors with better selectivity over IR than TAE226
Tao Chen, Yan Liu, Jiang Liu, et al.
Bioorganic Chemistry (2022) Vol. 124, pp. 105790-105790
Closed Access | Times Cited: 10
Discovery of novel chloropyramine-cinnamic acid hybrids as potential FAK inhibitors for intervention of metastatic triple-negative breast cancer
Fei Yang, Kang Xu, Sha Zhang, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 66, pp. 116809-116809
Closed Access | Times Cited: 10
α‐Catenin promotes dermal fibroblasts proliferation and migration during wound healing via FAK/YAP activation
Nan Wang, Xiejun Xu, Fangqian Guan, et al.
The FASEB Journal (2024) Vol. 38, Iss. 2
Closed Access | Times Cited: 1
Transcending traditional treatment: the therapeutical potential of nanovesicles for transdermal baclofen delivery in repeated traumatic brain injury
Nermin M. Sheta, Amira A. El-Gazar, Ghada M. Ragab, et al.
Advanced Pharmaceutical Bulletin (2024) Vol. 14, Iss. 2, pp. 346-363
Open Access | Times Cited: 1
Computational insights into allosteric inhibition of focal adhesion kinase: A combined pharmacophore modeling and molecular dynamics approach
Vikas Kumar, Pooja Singh, Shraddha Parate, et al.
Journal of Molecular Graphics and Modelling (2024) Vol. 130, pp. 108789-108789
Closed Access | Times Cited: 1
Design, synthesis, and biological evaluation of novel covalent inhibitors targeting focal adhesion kinase
Tao Chen, Yan Liu, Mingsong Shi, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 54, pp. 128433-128433
Closed Access | Times Cited: 12
Computational investigation of novel pyrimidine derivatives as potent FAK inhibitorsvia3D-QSAR, molecular docking, molecular dynamics simulation and retrosynthesis
Salma El Bahi, Meryem Boutalaka, Moulay Ahfid El Alaouy, et al.
New Journal of Chemistry (2023) Vol. 47, Iss. 27, pp. 12816-12829
Closed Access | Times Cited: 4
Combination Treatment of Retinoic Acid Plus Focal Adhesion Kinase Inhibitor Prevents Tumor Growth and Breast Cancer Cell Metastasis
Ana Carla Castro-Guijarro, Fiorella Vanderhoeven, Joselina Magali Mondaca, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2988-2988
Open Access | Times Cited: 7
Emerging kinase inhibitors for the treatment of pancreatic ductal adenocarcinoma
Udo Rudloff
Expert Opinion on Emerging Drugs (2022) Vol. 27, Iss. 3, pp. 345-368
Open Access | Times Cited: 7
Discovery of Novel Small-Molecule FAK Activators Promoting Mucosal Healing
Qinggang Wang, Ricardo Gallardo‐Macias, Rashmi Gupta, et al.
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 3, pp. 356-364
Open Access | Times Cited: 9
Discovery of Novel 2,4-Dianilinopyrimidine Derivatives Containing 4-(Morpholinomethyl)phenyl and N-Substituted Benzamides as Potential FAK Inhibitors and Anticancer Agents
Chun Han, Kemin Shen, Shijun Wang, et al.
Molecules (2021) Vol. 26, Iss. 14, pp. 4187-4187
Open Access | Times Cited: 6

Scroll to top